New Harbor Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
New Harbor Financial Group's XBI Position: Q2 2026 in Review
New Harbor Financial Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 146,497 shares worth $23.2M. The stake represents 3.66% of the portfolio and ranks #14 among its holdings. This is a return to the name: New Harbor Financial Group previously reported a position in XBI as recently as Q3 2013.
New Harbor Financial Group first reported a position in XBI in Q2 2013 and has held it in 3 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- New Harbor Financial Group held 146,497 shares of State Street SPDR S&P Biotech ETF worth $23.2M as of Q2 2026.
- State Street SPDR S&P Biotech ETF was a new New Harbor Financial Group position in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 3.66% of New Harbor Financial Group's portfolio in Q2 2026, its #14 holding.
- New Harbor Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 3 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on New Harbor Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.